Systematic review and meta-analysis of cell therapy for COVID-19: global clinical trial landscape, published safety/efficacy outcomes, cell product manufacturing and clinical delivery

During the pandemic of severe respiratory distress syndrome coronavirus 2 (SARS-CoV2), many novel therapeutic modalities to treat Coronavirus 2019 induced disease (COVID-19) were explored. This study summarizes 195 clinical trials of advanced cell therapies targeting COVID-19 that were registered ov...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Pedro S. Couto, Nada Al-Arawe, Igor S. Filgueiras, Dennyson L. M. Fonseca, Irene Hinterseher, Rusan A. Catar, Raghavan Chinnadurai, Alexey Bersenev, Otávio Cabral-Marques, Guido Moll, Frances Verter
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2023-06-01
coleção:	Frontiers in Immunology
Assuntos:	cell and gene therapy (CGT) advanced therapy medicinal products (ATMPs) mesenchymal stromal/stem cells (MSCs) severe respiratory distress syndrome coronavirus 2 (SARS-CoV2) coronavirus induced disease 2019 (COVID-19)
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1200180/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!